AVPdb: A database of experimentally validated antiviral peptides targeting medically important viruses

Nucleic Acids Research

Volumn 42, Issue D1, 2014, Pages

  Qureshi, Abid ^a   Thakur, Nishant ^a   Tandon, Himani ^a   Kumar, Manoj ^a  

^a INSTITUTE OF MICROBIAL TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; ANTIVIRUS PEPTIDE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; AMINO ACID; VIRUS PROTEIN; PEPTIDE;

ANTIVIRAL ACTIVITY; ANTIVIRAL PEPTIDE DATABASE; ARTICLE; COMPUTER INTERFACE; DENGUE VIRUS; DRUG DATABASE; DRUG EFFICACY; DRUG RESEARCH; DRUG STABILITY; DRUG STRUCTURE; DRUG TARGETING; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; ONLINE SYSTEM; PHYSICAL CHEMISTRY; PREDICTION; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VALIDATION PROCESS; WEB BROWSER; AMINO ACID SEQUENCE; AVPDB DATABASE; CONTROLLED STUDY; HEPATITIS B VIRUS; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INFLUENZA; PROTEIN DATABASE; PROTEIN DETERMINATION; PROTEIN MODIFICATION; PROTEIN TARGETING; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SARS CORONAVIRUS; CHEMICAL DATABASE; CHEMISTRY; COMPUTER PROGRAM; INTERNET;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; RICE STRIPE VIRUS; SIMPLEXVIRUS;

ANTIVIRAL AGENTS; DATABASES, CHEMICAL; INTERNET; PEPTIDES; SOFTWARE;

EID: 84891793411     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt1191     Document Type: Article

References (33)

1. Domingo, E. (2010) Mechanisms of viral emergence. Vet. Res., 41, 38.
2. Nichol, S.T., Arikawa, J. and Kawaoka, Y. (2000) Emerging viral diseases. Proc. Natl Acad. Sci. USA, 97, 12411-12412.
3. Duffy, S., Shackelton, L.A. and Holmes, E.C. (2008) Rates of evolutionary change in viruses: patterns and determinants. Nat. Rev. Genet., 9, 267-276.
4. Bacon, T.H., Levin, M.J., Leary, J.J., Sarisky, R.T. and Sutton, D. (2003) Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy. Clin. Microbiol. Rev., 16, 114-128.
5. Wyles, D.L. (2013) Antiviral resistance and the future landscape of hepatitis C virus infection therapy. J. Infect. Dis., 207(Suppl. 1), S33-39.
6. Tyagi, A., Ahmed, F., Thakur, N., Sharma, A., Raghava, G.P. and Kumar, M. (2011) HIVsirDB: a database of HIV inhibiting siRNAs. PLoS One, 6, e25917.
7. Thakur, N., Qureshi, A. and Kumar, M. (2012) VIRsiRNAdb: a curated database of experimentally validated viral siRNA/shRNA. Nucleic Acids Res., 40, D230-D236.
8. Jenssen, H. (2005) Anti herpes simplex virus activity of lactoferrin/lactoferricin-an example of antiviral activity of antimicrobial protein/peptide. Cell. Mol. Life Sci., 62, 3002-3013.
9. Budge, P.J. and Graham, B.S. (2004) Inhibition of respiratory syncytial virus by RhoA-derived peptides: implications for the development of improved antiviral agents targeting heparin-binding viruses. J. Antimicrob. Chemother., 54, 299-302.
10. Hancock, R.E. and Sahl, H.G. (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol., 24, 1551-1557.
11. Mujtaba, M.G., Patel, C.B., Patel, R.A., Flowers, L.O., Burkhart, M.A., Waiboci, L.W., Martin, J., Haider, M.I., Ahmed, C.M. and Johnson, H.M. (2006) The gamma interferon (IFN-gamma) mimetic peptide IFN-gamma (95-133) prevents encephalomyocarditis virus infection both in tissue culture and in mice. Clin. Vaccine Immunol., 13, 944-952.
12. Qureshi, A., Thakur, N. and Kumar, M. (2013) HIPdb: a database of experimentally validated HIV inhibiting peptides. PLoS One, 8, e54908.
13. Thakur, N., Qureshi, A. and Kumar, M. (2012) AVPpred: collection and prediction of highly effective antiviral peptides. Nucleic Acids Res., 40, W199-W204.
14. Imanishi, J., Oku, T., Cho, Y., Inagawa, S., Tanaka, A. and Kuwayama, W. (1985) C R Seances Soc Biol Fil., Inhibition of virus multiplication by immunoactive peptides. 179, 414-419.
15. Bultmann, H., Busse, J.S. and Brandt, C.R. (2001) Modified FGF4 signal peptide inhibits entry of herpes simplex virus type 1. J. Virol., 75, 2634-2645.
16. Guo, Y., Tisoncik, J., McReynolds, S., Farzan, M., Prabhakar, B.S., Gallagher, T., Rong, L. and Caffrey, M. (2009) Identification of a new region of SARS-CoV S protein critical for viral entry. J. Mol. Biol., 394, 600-605.
17. Nicol, M.Q., Ligertwood, Y., Bacon, M.N., Dutia, B.M. and Nash, A.A. (2012) A novel family of peptides with potent activity against influenza A viruses. J. Gen. Virol., 93, 980-986.
18. Xu, S., Li, H., Shao, X., Fan, C., Ericksen, B., Liu, J., Chi, C. and Wang, C. (2012) Critical effect of peptide cyclization on the potency of peptide inhibitors against Dengue virus NS2B-NS3 protease. J. Med. Chem., 55, 6881-6887.
19. Hong, W., Zhang, R., Di, Z., He, Y., Zhao, Z., Hu, J., Wu, Y., Li, W. and Cao, Z. (2013) Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus. Biomaterials, 34, 3511-3522.
20. Zasloff, M. (2002) Antimicrobial peptides of multicellular organisms. Nature, 415, 389-395.
21. Castel, G., Chteoui, M., Heyd, B. and Tordo, N. (2011) Phage display of combinatorial peptide libraries: application to antiviral research. Molecules, 16, 3499-3518.
22. Gentilucci, L., De Marco, R. and Cerisoli, L. (2010) Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization. Curr. Pharm. Des., 16, 3185-3203.
23. Fjell, C.D., Hiss, J.A., Hancock, R.E. and Schneider, G. (2012) Designing antimicrobial peptides: form follows function. Nat. Rev. Drug Discov., 11, 37-51.
24. Lalezari, J.P., Eron, J.J., Carlson, M., Cohen, C., DeJesus, E., Arduino, R.C., Gallant, J.E., Volberding, P., Murphy, R.L., Valentine, F. et al. (2003) A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy. Aids, 17, 691-698.
25. Williams, I.G. (2003) Enfuvirtide (Fuzeon): the first fusion inhibitor. Int. J. Clin. Pract., 57, 890-897.
26. Wang, G., Li, X. and Wang, Z. (2009) APD2: the updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res., 37, D933-D937.
27. Thomas, S., Karnik, S., Barai, R.S., Jayaraman, V.K. and Idicula-Thomas, S. (2010) CAMP: a useful resource for research on antimicrobial peptides. Nucleic Acids Res., 38, D774-D780.
28. Seshadri Sundararajan, V., Gabere, M.N., Pretorius, A., Adam, S., Christoffels, A., Lehvaslaiho, M., Archer, J.A. and Bajic, V.B. (2012) DAMPD: a manually curated antimicrobial peptide database. Nucleic Acids Res., 40, D1108-D1112.
29. Piotto, S.P., Sessa, L., Concilio, S. and Iannelli, P. (2012) YADAMP: yet another database of antimicrobial peptides. Int. J. Antimicrob. Agents, 39, 346-351.
30. Zhao, X., Wu, H., Lu, H., Li, G. and Huang, Q. (2013) LAMP: A database linking antimicrobial peptides. PLoS One, 8, e66557.
31. Kaur, H., Garg, A. and Raghava, G.P. (2007) PEPstr: a de novo method for tertiary structure prediction of small bioactive peptides. Protein Pept. Lett., 14, 626-631.
32. Thevenet, P., Shen, Y., Maupetit, J., Guyon, F., Derreumaux, P. and Tuffery, P. (2012) PEP-FOLD: an updated de novo structure prediction server for both linear and disulfide bonded cyclic peptides. Nucleic Acids Res., 40, W288-W293.
33. Kawashima, S., Pokarowski, P., Pokarowska, M., Kolinski, A., Katayama, T. and Kanehisa, M. (2008) AAindex: amino acid index database, progress report 2008. Nucleic Acids Res., 36, D202-D205.